Takeda

This study monitors how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) during routine medical care in South Korea. HAE causes sudden, severe swelling under the skin or inside the body. Researchers will track side effects and how well the …

This study aims to understand how well the preventive drug Takhzyro works for people with hereditary angioedema (HAE) in real-world settings in Saudi Arabia. Researchers will review the medical records of about 50 patients who have taken the drug for at least six months to see if…

This study aims to monitor the long-term safety of Adzynma, a replacement enzyme therapy for people with congenital thrombotic thrombocytopenic purpura (cTTP), a rare inherited blood clotting disorder. Researchers will review medical records of about 50 patients who have already …

This study is testing an investigational drug called TAK-226 to see if it can help Japanese adults with a lower-risk bone marrow disorder become less dependent on regular blood transfusions. The main goal is to see if participants can go at least 8 weeks without needing a transfu…

This study is testing an investigational pill called zasocitinib for adults with active Crohn's disease. The main goals are to understand how the drug works at a cellular level in the gut and to check its safety. About 20 participants will take the drug for 12 weeks and undergo a…

This study is testing an experimental drug called TAK-755 in adults who have just had an ischemic stroke, which is caused by a blood clot blocking blood flow to the brain. The main goals are to see if the drug is safe and if it helps people recover their ability to perform daily …

This study looks back at medical records to understand how a manufactured enzyme therapy helped people with a rare, inherited blood disorder called congenital TTP. The therapy, called rADAMTS13, is designed to replace a missing enzyme to help prevent dangerous blood clots. Resear…

This study aims to check the long-term safety and effectiveness of the daily pill zasocitinib for adults with active psoriatic arthritis. It is a 2-year follow-up study for about 1,200 people who completed a previous 1-year trial. The main goal is to monitor side effects and see …

This is the first time a new drug called TAK-505 is being given to people. The study aims to find a safe and effective dose for adults with advanced solid tumors—specifically certain stomach, lung, bowel, and head/neck cancers that have spread and are no longer responding to stan…

This study aims to see if a simpler blood test that measures just one protein function can accurately diagnose hereditary angioedema (HAE), a rare condition causing sudden, serious swelling. Researchers in Algeria will compare this new test approach to the standard combination of…

This study aims to understand how hereditary angioedema (HAE) is diagnosed and treated in Egypt. It will look at the medical records of about 100 people with HAE and follow some of them during their regular doctor visits. The goal is to learn about their experiences, from first s…

This study aims to compare the risk of serious infections in older adults (65+) with Ulcerative Colitis or Crohn's Disease when they start different advanced medications. It will look back at the medical records of about 23,900 people on Medicare from 2016 to 2025 to see if one t…